Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
Clinical trial NCT04799847 · UNKNOWN
Trial details
- NCT number
- NCT04799847
- Sponsor
- LintonPharm Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-23
- Primary completion
- 2024-11-30
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.